More Than 450 Companies Adopt Veeva Vault eTMF for Improved Trial Efficiency and Inspection Readiness
PLEASANTON, Calif., June 5, 2023 /PRNewswire/ -- As the industry advances clinical operations, adopting applications on a unified platform is a top priority to increase study efficiency and compliance. More than 450 biopharma companies—including 18 of the top 20 pharmas and 4 of the top 6 CROs—use Veeva Vault eTMF to automate trial processes and improve information exchange across stakeholders.
- As regulatory and trial complexity grows, more companies are increasing transparency and inspection readiness with Vault eTMF.
- Seamless connection between Vault eTMF and Veeva Vault RIM to increase efficiency and collaboration between clinical and regulatory teams.
- Vault eTMF is part of Veeva Vault Clinical Suite , the industry's first cloud platform that unifies clinical data management and operations.
- Vault Clinical Suite includes Vault eTMF, Vault CTMS , Veeva Site Connect , Vault Payments , Vault Study Start-up , Vault Study Training , Vault EDC , Veeva CDB , Veeva RTSM , and Veeva ePRO .